125 related articles for article (PubMed ID: 18772160)
21. Effects of echinocandins on cytokine/chemokine production by human monocytes activated by infection with Candida glabrata or by lipopolysaccharide.
Baltch AL; Lawrence DA; Ritz WJ; Andersen NJ; Bopp LH; Michelsen PB; Carlyn CJ; Smith RP
Diagn Microbiol Infect Dis; 2012 Mar; 72(3):226-33. PubMed ID: 22209510
[TBL] [Abstract][Full Text] [Related]
22. Antifungal activity against Candida albicans of nikkomycin Z in combination with caspofungin, voriconazole or amphotericin B.
Sandovsky-Losica H; Shwartzman R; Lahat Y; Segal E
J Antimicrob Chemother; 2008 Sep; 62(3):635-7. PubMed ID: 18490373
[No Abstract] [Full Text] [Related]
23. In vitro activity of caspofungin and voriconazole against uncommon Candida spp.
Enache-Angoulvant A; Girard A; Poirot JL; Hennequin C
Int J Antimicrob Agents; 2009 Jun; 33(6):595-6. PubMed ID: 19162450
[No Abstract] [Full Text] [Related]
24. IFN-gamma enhances killing of methicillin-resistant Staphylococcus aureus by human monocytes more effectively than GM-CSF in the presence of daptomycin and other antibiotics.
Smith RP; Baltch AL; Ritz WJ; Michelsen PB; Bopp LH
Cytokine; 2010 Sep; 51(3):274-7. PubMed ID: 20580568
[TBL] [Abstract][Full Text] [Related]
25. The evaluation of in vitro pharmacodynamic properties of amphotericin B, voriconazole and caspofungin against A. fumigatus isolates by the conventional and colorimetric time-kill assays.
Kiraz N; Oz Y; Dag I
Med Mycol; 2011 Aug; 49(6):594-601. PubMed ID: 21299374
[TBL] [Abstract][Full Text] [Related]
26. Immunomodulatory effects of voriconazole and caspofungin on human peripheral blood mononuclear cells stimulated by Candida albicans and Candida krusei.
Fidan I; Yesilyurt E; Kalkanci A; Aslan SO; Sahin N; Ogan MC; Dizbay M
Am J Med Sci; 2014 Sep; 348(3):219-23. PubMed ID: 24662309
[TBL] [Abstract][Full Text] [Related]
27. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
28. In vitro fungicidal activities of anidulafungin, caspofungin, and micafungin against Candida glabrata, Candida bracarensis, and Candida nivariensis evaluated by time-kill studies.
Gil-Alonso S; Jauregizar N; Cantón E; Eraso E; Quindós G
Antimicrob Agents Chemother; 2015; 59(6):3615-8. PubMed ID: 25801575
[TBL] [Abstract][Full Text] [Related]
29. Postantifungal effect of the combination of caspofungin with voriconazole and amphotericin B against clinical Candida krusei isolates.
Oz Y; Kiremitci A; Dag I; Metintas S; Kiraz N
Med Mycol; 2013 Jan; 51(1):60-5. PubMed ID: 22746405
[TBL] [Abstract][Full Text] [Related]
30. In vitro activities of voriconazole in combination with three other antifungal agents against Candida glabrata.
Barchiesi F; Spreghini E; Maracci M; Fothergill AW; Baldassarri I; Rinaldi MG; Scalise G
Antimicrob Agents Chemother; 2004 Sep; 48(9):3317-22. PubMed ID: 15328091
[TBL] [Abstract][Full Text] [Related]
31. Comparison of antifungal susceptibilities to fluconazole and voriconazole of oral Candida glabrata isolates from head and neck radiation patients.
Burn AK; Fothergill AW; Kirkpatrick WR; Coco BJ; Patterson TF; McCarthy DI; Rinaldi MG; Redding SW
J Clin Microbiol; 2004 Dec; 42(12):5846-8. PubMed ID: 15583322
[TBL] [Abstract][Full Text] [Related]
32.
Fakhim H; Chowdhary A; Prakash A; Vaezi A; Dannaoui E; Meis JF; Badali H
Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28848002
[TBL] [Abstract][Full Text] [Related]
33. Activity of voriconazole combined with neutrophils or monocytes against Aspergillus fumigatus: effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor.
Vora S; Chauhan S; Brummer E; Stevens DA
Antimicrob Agents Chemother; 1998 Sep; 42(9):2299-303. PubMed ID: 9736553
[TBL] [Abstract][Full Text] [Related]
34. Phase-dependent antifungal activity against Aspergillus fumigatus developing multicellular filamentous biofilms.
Mowat E; Lang S; Williams C; McCulloch E; Jones B; Ramage G
J Antimicrob Chemother; 2008 Dec; 62(6):1281-4. PubMed ID: 18819968
[TBL] [Abstract][Full Text] [Related]
35. Effect of granulocyte-macrophage colony-stimulating factor on candidacidal activity of neutrophils, monocytes or monocyte-derived macrophages and synergy with fluconazole.
Natarajan U; Randhawa N; Brummer E; Stevens DA
J Med Microbiol; 1998 Apr; 47(4):359-63. PubMed ID: 9569003
[TBL] [Abstract][Full Text] [Related]
36. In vitro biofilm characterization and activity of antifungal agents alone and in combination against sessile and planktonic clinical Candida albicans isolates.
Shuford JA; Piper KE; Steckelberg JM; Patel R
Diagn Microbiol Infect Dis; 2007 Mar; 57(3):277-81. PubMed ID: 17141454
[TBL] [Abstract][Full Text] [Related]
37. Caspofungin activity against clinical isolates of azole cross-resistant Candida glabrata overexpressing efflux pump genes.
Posteraro B; Sanguinetti M; Fiori B; La Sorda M; Spanu T; Sanglard D; Fadda G
J Antimicrob Chemother; 2006 Aug; 58(2):458-61. PubMed ID: 16757500
[TBL] [Abstract][Full Text] [Related]
38. Biguanides enhance antifungal activity against Candida glabrata.
Xu S; Feliu M; Lord AK; Lukason DP; Negoro PE; Khan NS; Dagher Z; Feldman MB; Reedy JL; Steiger SN; Tam JM; Soukas AA; Sykes DB; Mansour MK
Virulence; 2018; 9(1):1150-1162. PubMed ID: 29962263
[TBL] [Abstract][Full Text] [Related]
39. Effects of caspofungin, Candida albicans and Aspergillus fumigatus on toll-like receptor 9 of GM-CSF-stimulated PMNs.
Salvenmoser S; Seidler MJ; Dalpke A; Müller FM
FEMS Immunol Med Microbiol; 2010 Oct; 60(1):74-7. PubMed ID: 20626764
[TBL] [Abstract][Full Text] [Related]
40. National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin.
Takakura S; Fujihara N; Saito T; Kudo T; Iinuma Y; Ichiyama S
J Antimicrob Chemother; 2004 Feb; 53(2):283-9. PubMed ID: 14688039
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
